X-ray contrast media flat at Mallinckrodt
This article was originally published in Clinica
Executive Summary
Mallinckrodt Medical's first-quarter imaging sales grew only 1% to $161.2 million, compared with 11% in fiscal 1995. Mallinckrodt Group CEO Ray Holman blamed this on lower growth in X-ray contrast media sales resulting principally from order timing and distributor inventory adjustments.